Improving vaccines by targeting antigens to dendritic cells
Open Access
- 1 January 2009
- journal article
- review article
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 41 (2) , 61-66
- https://doi.org/10.3858/emm.2009.41.2.008
Abstract
Experimental & Molecular Medicine is an open access journal that publishes the highest quality articles in translational research and biomedical studies.Keywords
This publication has 38 references indexed in Scilit:
- The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancementBlood, 2008
- Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectinJournal of Clinical Investigation, 2008
- CLEC9A Is a Novel Activation C-type Lectin-like Receptor Expressed on BDCA3+ Dendritic Cells and a Subset of MonocytesJournal of Biological Chemistry, 2008
- Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD miceProceedings of the National Academy of Sciences, 2008
- The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccineProceedings of the National Academy of Sciences, 2008
- Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNature Reviews Immunology, 2007
- A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12–independent but CD70-dependent mechanism in vivoThe Journal of Experimental Medicine, 2007
- Differential Antigen Processing by Dendritic Cell Subsets in VivoScience, 2007
- The dominant role of CD8+dendritic cells in cross-presentation is not dictated by antigen captureProceedings of the National Academy of Sciences, 2006
- Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHCNature, 1987